Patents by Inventor Hans H. Sonneborn

Hans H. Sonneborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6120989
    Abstract: Diagnostically relevant polypeptides and fusion proteins comprising an amino acid sequence which originates from cytomegalovirus and corresponds to a region of the major DNA-binding protein or of the C-terminal region of the tegument protein pp150 fused with at least one further fragment from another antigenic protein of cytomegalovirus are disclosed. The major DNA-binding protein is encoded by the reading frame UL57. The poly-peptides and fusion proteins according to the invention can be used in an advantageous manner in diagnostic tests and methods for the detection of IgM antibodies against cytomegalovirus.
    Type: Grant
    Filed: July 25, 1995
    Date of Patent: September 19, 2000
    Assignee: Biotest AG
    Inventors: Rolf Vornhagen, Walter Hinderer, Hans-H. Sonneborn, Bodo Plachter, Gerhard Jahn
  • Patent number: 4751183
    Abstract: Monoclonal antibodies that recognize a structure common to human interleukin-2 and to the light .lambda. chain of human immunoglobulin and lines of hybridoma cells that produce these monoclonal antibodies can be prepared by immunizing animals, especially mice, with human interleukin-2 (TCGF) and fusing the splenocytes obtained from the animals with animal, expecially mouse, myeloma cells to create a hybridoma. The hybridomas are raised as clones and the antibodies obtained from the individual clones tested for their specificity to human interleukin-2 (TCGF). Clones that produce antibodies with a specificity to human interleukin-2 (TCGF) are selected for further raising to prepare the antibody. The antibody is harvested from the culture medium or from the ascitic fluids of the animal, especially the mouse, with the hybridoma.
    Type: Grant
    Filed: August 15, 1984
    Date of Patent: June 14, 1988
    Assignee: Biotest-Serum-Institut GmbH
    Inventors: Hans H. Sonneborn, Rolf M. Vornhagen, Udo Schwulera
  • Patent number: 4678753
    Abstract: A blood-culture flask with an integrated subculture. It comprises a flask proper that can be filled with a liquid nutrient solution and has a neck with an outside thread, a support that can be coated with a solid culture medium, a resilient stopper with an edge that projects at one end, and a screw cap. The screw cap consists of a bottom that is open above and below and has an inside thread and of a top that is open below. The inside thread is dimensioned so that it can be screwed down over the outside thread on the neck of the flask so that the upper edge of the thread is below the upper edge of the neck when screwed on. The resilient stopper is positioned inside the bottom of the screw cap so that the bottom surface of its resilient projecting edge comes to rest against the offset above the thread when not screwed on and its lower section is dimensioned so that it can be introduced tight into the neck of the flask.
    Type: Grant
    Filed: August 26, 1985
    Date of Patent: July 7, 1987
    Assignee: Biotest-Serum-Institut GmbH
    Inventors: Hans D. Hempel, Jurgen Horn, Wilfried Rothermel, Hans H. Sonneborn, Michael Becker, Ullrich Muller
  • Patent number: 4508833
    Abstract: Crude interleukin-2 extract is subjected to group-selective dye-ligand absorption chromatography in one or more stages of purification with a matrix-gel medium consisting of a Blue A ligand or variant thereof or of a Green A ligand in a concentration of approximately 1.5 to 3.0 mg/ml of expanded matrix at a pH of approximately 6.8 to 8.5, a temperature of approximately 4.degree. to 40.degree. C., and a flowthrough rate of approximately 10 to 100 ml/h, employing an eluent. Either PHA-free or extremely pure interleukin-2 is obtained, depending on the overall number of purification stages.
    Type: Grant
    Filed: December 14, 1982
    Date of Patent: April 2, 1985
    Assignee: Biotest-Serum-Institut GmbH
    Inventors: Hans H. Sonneborn, Udo Schwulera, Hans Schleussner